Origins of cancer symposium 2016: Exploring tumor complexity

Genes and Cancer

Volumn 7, Issue 9-10, 2016, Pages 288-291

  Harlow, Matt ^a   Lee, Kwang Ho ^b   Winn, Mary ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Mediator; Review; Therapy resistance; Tumor complexity; Tumor evolution

Indexed keywords

CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 8; SUCCINATE DEHYDROGENASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ARTICLE; CANCER RESEARCH; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; HISTONE METHYLATION; HUMAN; MALIGNANT NEOPLASM; MELANOMA; PHYLOGENETIC TREE; POINT MUTATION; PROTEIN EXPRESSION; SYMPOSIUM; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 85014052855     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.18632/genesandcancer.119     Document Type: Article

References (28)

1. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz A, McCombie WR, Hicks J and Wigler M. Tumour evolution inferred by single-cell sequencing. Nature. 2011; 472:90-94.
2. Fearon ER and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61:759-767.
3. Hoglund M, Gisselsson D, Hansen GB, Sall T and Mitelman F. Multivariate analysis of chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals complex relationships among imbalances. Cancer Res. 2002; 62:2675-2680.
4. Wang Y, Waters J, Leung ML, Unruh A, Roh W, Shi X, Chen K, Scheet P, Vattathil S, Liang H, Multani A, Zhang H, Zhao R, Michor F, Meric-Bernstam F and Navin NE. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014; 512:155-160.
5. Bielas JH and Loeb LA. Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen. 2005; 45:206-213.
6. Lunt SY and Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011; 27:441-464.
7. Vander Heiden MG, Lunt SY, Dayton TL, Fiske BP, Israelsen WJ, Mattaini KR, Vokes NI, Stephanopoulos G, Cantley LC, Metallo CM and Locasale JW. Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol. 2011; 76:325-334.
8. Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A, Yang H, Mattaini KR, Metallo CM, Fiske BP, Courtney KD, Malstrom S, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol. 2012; 8:839-847.
9. Lunt SY, Muralidhar V, Hosios AM, Israelsen WJ, Gui DY, Newhouse L, Ogrodzinski M, Hecht V, Xu K, Acevedo PN, Hollern DP, Bellinger G, Dayton TL, Christen S, Elia I, Dinh AT, et al. Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol Cell. 2015; 57:95-107.
10. Aspuria PJ, Lunt SY, Varemo L, Vergnes L, Gozo M, Beach JA, Salumbides B, Reue K, Wiedemeyer WR, Nielsen J, Karlan BY and Orsulic S. Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab. 2014; 2:21.
11. Pelish HE, Liau BB, Nitulescu, II, Tangpeerachaikul A, Poss ZC, Da Silva DH, Caruso BT, Arefolov A, Fadeyi O, Christie AL, Du K, Banka D, Schneider EV, Jestel A, Zou G, Si C, et al. Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature. 2015; 526:273-276.
12. Poss ZC, Ebmeier CC, Odell AT, Tangpeerachaikul A, Lee T, Pelish HE, Shair MD, Dowell RD, Old WM and Taatjes DJ. Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016; 15:436-450.
13. Moreau LA, McGrady P, London WB, Shimada H, Cohn SL, Maris JM, Diller L, Look AT and George RE. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children’s Oncology Group study. Clin Cancer Res. 2006; 12:5693-5697.
14. Chipumuro E, Marco E, Christensen CL, Kwiatkowski N, Zhang T, Hatheway CM, Abraham BJ, Sharma B, Yeung C, Altabef A, Perez-Atayde A, Wong KK, Yuan GC, Gray NS, Young RA and George RE. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014; 159:1126-1139.
15. Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI, Polsky D, Osman I, Garcia BA, Hernando E and Bernstein E. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature. 2010; 468:1105-1109.
16. Vardabasso C, Hake SB and Bernstein E. Histone variant H2A.Z.2: A novel driver of melanoma progression. Mol Cell Oncol. 2016; 3:e1073417.
17. Gaspar-Maia A, Qadeer ZA, Hasson D, Ratnakumar K, Leu NA, Leroy G, Liu S, Costanzi C, Valle-Garcia D, Schaniel C, Lemischka I, Garcia B, Pehrson JR and Bernstein E. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat Commun. 2013; 4:1565.
18. Lombardo MJ, Aponyi I and Rosenberg SM. General stress response regulator RpoS in adaptive mutation and amplification in Escherichia coli. Genetics. 2004; 166:669-680.
19. McKenzie GJ, Harris RS, Lee PL and Rosenberg SM. The SOS response regulates adaptive mutation. Proc Natl Acad Sci U S A. 2000; 97:6646-6651.
20. Gibson JL, Lombardo MJ, Thornton PC, Hu KH, Galhardo RS, Beadle B, Habib A, Magner DB, Frost LS, Herman C, Hastings PJ and Rosenberg SM. The sigma(E) stress response is required for stress-induced mutation and amplification in Escherichia coli. Mol Microbiol. 2010; 77:415-430.
21. Harris RS, Longerich S and Rosenberg SM. Recombination in adaptive mutation. Science. 1994; 264:258-260.
22. McKenzie GJ, Lee PL, Lombardo MJ, Hastings PJ and Rosenberg SM. SOS mutator DNA polymerase IV functions in adaptive mutation and not adaptive amplification. Mol Cell. 2001; 7:571-579.
23. Rosenberg SM, Longerich S, Gee P and Harris RS. Adaptive mutation by deletions in small mononucleotide repeats. Science. 1994; 265:405-407.
24. Ponder RG, Fonville NC and Rosenberg SM. A switch from high-fidelity to error-prone DNA double-strand break repair underlies stress-induced mutation. Mol Cell. 2005; 19:791-804.
25. Shee C, Gibson JL, Darrow MC, Gonzalez C and Rosenberg SM. Impact of a stress-inducible switch to mutagenic repair of DNA breaks on mutation in Escherichia coli. Proc Natl Acad Sci U S A. 2011; 108:13659-13664.
26. Shee C, Gibson JL and Rosenberg SM. Two mechanisms produce mutation hotspots at DNA breaks in Escherichia coli. Cell Rep. 2012; 2:714-721.
27. Wimberly H, Shee C, Thornton PC, Sivaramakrishnan P, Rosenberg SM and Hastings PJ. R-loops and nicks initiate DNA breakage and genome instability in non-growing Escherichia coli. Nat Commun. 2013; 4:2115.
28. Al Mamun AA, Lombardo MJ, Shee C, Lisewski AM, Gonzalez C, Lin D, Nehring RB, Saint-Ruf C, Gibson JL, Frisch RL, Lichtarge O, Hastings PJ and Rosenberg SM. Identity and function of a large gene network underlying mutagenic repair of DNA breaks. Science. 2012; 338:1344-1348.